Kathy Giusti

Giusti is the founder and chief mission officer of the Multiple Myeloma Research Foundation (MMRF). Since the MMRF was founded, 15 drugs have been approved to treat multiple myeloma. She also co-chairs and helped found the Harvard Business School Kraft Precision Medicine Accelerator. She previously held leadership roles at G.D. Searle and Merck.

  • March 2022

Added to: EQRx - Cambridge, MA

EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices.